Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celestia S Higano

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Urologic Oncology|December 30, 2008
Positive surgical margins: the argument for androgen deprivation and chemotherapyCelestia S Higano
The Urologic Clinics of North America|May 5, 2004
Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinicianCelestia S Higano
The Canadian Journal of Urology|July 16, 2005
Current status of treatment for patients with metastatic prostate cancerCelestia S Higano
The Journal of Urology|November 12, 2003
Management of bone loss in men with prostate cancerCelestia S Higano
Urologic Oncology|December 13, 2003
Bone loss and the evolving role of bisphosphonate therapy in prostate cancerCelestia S Higano
Urologic Oncology|September 9, 2020
Update on cardiovascular and metabolic risk profiles of hormonal agents used in managing advanced prostate cancerCelestia S Higano
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
Intermittent versus continuous androgen deprivation therapyCelestia S Higano
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
New developments in the treatment of castration-resistant prostate cancerCelestia S Higano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancerCelestia S Higano
Oncotargets and Therapy|July 10, 2013
Potential use of custirsen to treat prostate cancerCelestia S Higano
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Urologic Oncology|December 30, 2008
Positive surgical margins: the argument for androgen deprivation and chemotherapyCelestia S Higano
The Urologic Clinics of North America|May 5, 2004
Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinicianCelestia S Higano
The Canadian Journal of Urology|July 16, 2005
Current status of treatment for patients with metastatic prostate cancerCelestia S Higano
The Journal of Urology|November 12, 2003
Management of bone loss in men with prostate cancerCelestia S Higano
Urologic Oncology|December 13, 2003
Bone loss and the evolving role of bisphosphonate therapy in prostate cancerCelestia S Higano
Urologic Oncology|September 9, 2020
Update on cardiovascular and metabolic risk profiles of hormonal agents used in managing advanced prostate cancerCelestia S Higano
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
Intermittent versus continuous androgen deprivation therapyCelestia S Higano
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
New developments in the treatment of castration-resistant prostate cancerCelestia S Higano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancerCelestia S Higano
Oncotargets and Therapy|July 10, 2013
Potential use of custirsen to treat prostate cancerCelestia S Higano
Pageof 21